Complimentary Technical Snapshots on ViewRay and Three More Medical Equipment Stocks

Stock Research Monitor: SYK, WMGI, and ZBH

LONDON, UK / ACCESSWIRE / June 08, 2018 / If you want a free Stock Review on VRAY sign up now at www.wallstequities.com/registration. WallStEquities.com revisits the Medical Appliances and Equipment space, which comprises companies that are engaged in the manufacture of medical instruments, such as dental and surgical appliances. Companies in this category tend to offer below-average dividend yields when compared to the wider market. In this morning’s lineup are the following equities: Stryker Corp. (NYSE: SYK), ViewRay Inc. (NASDAQ: VRAY), Wright Medical Group N.V. (NASDAQ: WMGI), and Zimmer Biomet Holdings Inc. (NYSE: ZBH). All you have to do is sign up today for this free limited time offer by clicking the link below.

www.wallstequities.com/registration

Stryker

Shares in Kalamazoo, Michigan headquartered Stryker Corp. saw a slight decline of 0.91%, ending Thursday’s trading session at $178.15. The stock recorded a trading volume of 831,961 shares. The Company’s shares have gained 6.92% in the last month, 9.06% over the last three months, and 23.34% over the past year. The stock is trading 6.71% and 13.38% above its 50-day and 200-day moving averages, respectively. Moreover, shares of Stryker, which operates as a medical technology company, have a Relative Strength Index (RSI) of 66.19. Get the full research report on SYK for free by clicking below at:

www.wallstequities.com/registration/?symbol=SYK

ViewRay

Oakwood Village, Ohio headquartered ViewRay Inc.’s stock dropped 5.84%, closing the day at $7.25. A total volume of 987,747 shares was traded, which was above their three months average volume of 632,420 shares. The Company’s shares have advanced 8.53% over the past year. The stock is trading 0.94% above its 50-day moving average. Additionally, shares of ViewRay, which through its subsidiary, ViewRay Technologies, Inc., designs, manufactures, and markets radiation therapy systems, have an RSI of 49.29.

On June 04th, 2018, ViewRay announced that James F. Dempsey, PhD, Founder and Chief Scientific Officer, and Ajay Bansal, CFO, are scheduled to present at the Jefferies 2018 Global Healthcare Conference on June 08th, 2018, at 10:30 a.m. ET in New York. An audio webcast of the presentation will be available under the investor relations section of the Company’s website. Access the free research report on VRAY now by signing up at:

www.wallstequities.com/registration/?symbol=VRAY

Wright Medical Group

On Thursday, shares in Amsterdam, the Netherlands headquartered Wright Medical Group N.V. recorded a trading volume of 776,829 shares. The stock ended the day 1.68% lower at $24.51. The Company’s shares have advanced 18.06% in the past month and 19.33% in the previous three months. The stock is trading above its 50-day and 200-day moving averages by 13.18% and 4.57%, respectively. Furthermore, shares of Wright Medical, which designs, manufactures, markets, and sells extremities and biologics products, have an RSI of 63.04. Are you already registered with Wall St. Equities? Do so now for free, and get the report on WMGI at:

www.wallstequities.com/registration/?symbol=WMGI

Zimmer Biomet Holdings

Warsaw, Indiana headquartered Zimmer Biomet Holdings Inc.’s stock declined slightly by 0.45%, finishing yesterday’s session at $113.67 with a total trading volume of 706,908 shares. The Company’s shares are trading above their 50-day moving average by 1.74%. The stock, which together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, EMEA region, and Asia/Pacific, have an RSI of 53.89.

On May 22nd, 2018, Zimmer Biomet announced that it has received 510(k) clearance from the US FDA for its Zyston® Strut Open Titanium Interbody Spacer System. This marks the Company’s first titanium spinal implant manufactured via a 3D printing process. Aspiring Member, please take a moment to register below for your free research report on ZBH at:

www.wallstequities.com/registration/?symbol=ZBH

Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

WSE has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@wallstequities.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

https://wallstequities.com/legal-disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@wallstequities.com

Phone number: 21 32 044 483

Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Wall St. Equities

ReleaseID: 502101